Skip to main content
Clinical Trials/JPRN-UMIN000013562
JPRN-UMIN000013562
Completed
未知

The development of bacterial infection as an adverse effect in telaprevir-based triple therapy for chronic hepatitis C - Bacterial infection during telaprevir-based triple therapy

The Kyushu University Liver Disease Study0 sites400 target enrollmentMarch 30, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
Chronic hepatitis C
Sponsor
The Kyushu University Liver Disease Study
Enrollment
400
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 30, 2014
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
The Kyushu University Liver Disease Study

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Positivity for antibody to human immunodeficiency virus or positivity for hepatitis B surface antigen, clinical or biochemical evidence of hepatic decompensation, hepatocellular carcinoma at entry

Outcomes

Primary Outcomes

Not specified

Similar Trials